Edition:
United States

Teva Pharmaceutical Industries Ltd (TEVA.N)

TEVA.N on New York Stock Exchange

7.91USD
19 Jul 2019
Change (% chg)

$0.08 (+1.02%)
Prev Close
$7.83
Open
$7.87
Day's High
$8.00
Day's Low
$7.77
Volume
3,588,094
Avg. Vol
3,250,994
52-wk High
$25.96
52-wk Low
$7.67

About

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic... (more)

Overall

Beta: 1.63
Market Cap(Mil.): $8,642.67
Shares Outstanding(Mil.): 1,092.46
Dividend: 0.09
Yield (%): --

Financials

  TEVA.N Industry Sector
P/E (TTM): -- 30.63 34.52
EPS (TTM): -3.42 -- --
ROI: -7.51 13.02 12.69
ROE: -23.76 14.18 17.17

Teva loses challenge to Bausch patent on drug Relistor

Canadian pharmaceutical company Bausch Health Companies Inc (formerly Valeant Pharmaceuticals) on Wednesday won a ruling protecting its drug Relistor from U.S. generic competition from Teva Pharmaceuticals Industries Ltd.

Jul 18 2019

Oklahoma judge approves Teva's $85 million opioid settlement

An Oklahoma judge on Monday approved a revised $85 million settlement with Teva Pharmaceutical Industries Ltd resolving claims by the state's attorney general that the drugmaker helped fuel the U.S. opioid epidemic.

Jun 24 2019

Oklahoma judge approves Teva's $85 million opioid settlement

June 24 An Oklahoma judge on Monday approved a revised $85 million settlement with Teva Pharmaceutical Industries Ltd resolving claims by the state's attorney general that the drugmaker helped fuel the U.S. opioid epidemic.

Jun 24 2019

Oklahoma judge mulls governor's concerns over Teva opioid settlement

An Oklahoma judge on Monday asked the state's attorney general to respond to arguments by the state's governor and legislative leaders that Teva Pharmaceutical Industries Ltd's $85 million opioid litigation settlement violates a new law they say requires the funds to be deposited in the state's treasury.

Jun 17 2019

Teva Pharm to pay Oklahoma $85 million to settle opioid claims

BOSTON/JERUSALEM Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic. | Video

May 27 2019

UPDATE 2-Teva Pharm to pay Oklahoma $85 mln to settle opioid claims

BOSTON/JERUSALEM, May 26 Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic.

May 26 2019

Oklahoma reaches $85 mln settlement with Teva Pharmaceuticals ahead of trial

May 26 Oklahoma has reached a $85 million settlement agreement with Israeli-based Teva Pharmaceutical Industries Ltd ahead of the start of a trial in a multibillion-dollar lawsuit over the opioid epidemic, the state's attorney general said on Sunday.

May 26 2019

J&J, Teva lose last-minute bid to escape Oklahoma opioid lawsuit

An Oklahoma judge on Monday cleared the way for Johnson & Johnson and Teva Pharmaceutical Industries Ltd to face trial at the end of May in a lawsuit by the state's attorney general accusing the drugmakers of helping fuel the opioid epidemic.

May 13 2019

Teva Pharm CFO says company did not conspire to fix prices

JERUSALEM Teva Pharmaceutical Industries' chief financial officer on Sunday reiterated that the company has done nothing wrong in the wake of a price-fixing lawsuit filed by 44 U.S. states.

May 12 2019

Teva Pharm CFO says company did not conspire to fix prices

JERUSALEM, May 12 Teva Pharmaceutical Industries' chief financial officer on Sunday reiterated that the company has done nothing wrong in the wake of a price-fixing lawsuit filed by 44 U.S. states.

May 12 2019

Earnings vs. Estimates